Negative impact of high body mass index on the efficacy of anti-TNFα agents in patients with Inflammatory Bowel Disease

被引:0
|
作者
Hamoir, F. [1 ]
De Leuze, F. [1 ]
Denis, M. [1 ]
De Vroey, B. [1 ]
De Suray, N. [1 ]
Burnet, G. [1 ]
Piessevaux, H. [1 ]
Dewit, O. [1 ]
机构
[1] Clin Univ St Luc, Gastroenterol, Brussels, Belgium
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P591
引用
收藏
页码:719 / 720
页数:2
相关论文
共 50 条
  • [31] Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
    Sochal, Marcin
    Fichna, Jakub
    Gabryelska, Agata
    Talar-Wojnarowska, Renata
    Bialasiewicz, Piotr
    Malecka-Wojciesko, Ewa
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [32] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309
  • [33] Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease
    Guerra, Ivan
    Chaparro, Maria
    Bermejo, Fernando
    Gisbert, Javier P.
    CURRENT DRUG METABOLISM, 2014, 15 (09) : 875 - 881
  • [34] Efficacy, safety and durability of anti-TNF therapy in the treatment of inflammatory bowel disease
    Trivedi, Chirag
    Kao, James
    Saxena, Mark
    Shen, Eric
    Das, Kiron
    Ebert, Ellen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S448 - S448
  • [35] CLINICAL EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASE IN THE ELDERLY
    Digby-Bell, Jonathan
    Ibraheim, Hajir
    Badrulhisham, Fakhirah
    Powell, Nick
    GUT, 2018, 67 : A75 - A75
  • [36] Familial Aggregation in the Response to Anti-TNF in Inflammatory Bowel Disease Patients
    Billiet, Thomas
    Cleynen, Isabelle
    Ballet, Vera
    Ferrante, Marc
    Van Steen, Kristel
    Rutgeerts, Paul J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2013, 144 (05) : S647 - S647
  • [37] Lipid Profile in Inflammatory Bowel Disease Patients on Anti-TNFα Therapy
    Miranda-Bautista, Jose
    de Gracia-Fernandez, Celia
    Lopez-Ibanez, Maria
    Barrientos, Maria
    Gallo-Molto, Alejandra
    Gonzalez-Arias, Marina
    Gonzalez-Gil, Casilda
    Diaz-Redondo, Alicia
    Marin-Jimenez, Ignacio
    Menchen, Luis
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (07) : 2130 - 2135
  • [38] Anti-TNF Treatment in Inflammatory Bowel Disease Patients Diagnosed in Adolescence
    Naik, Amar S.
    Asamoah, Nikiya
    Zadvornova, Yelena
    Perera, Lilani P.
    Stein, Daniel J.
    Saeian, Kia
    Venu, Nanda
    GASTROENTEROLOGY, 2012, 142 (05) : S362 - S362
  • [39] ANTI-TNF THERAPY INDUCED ARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Reilly, Elizabeth
    Edwards, Cathryn
    Mackay, Kirsten
    RHEUMATOLOGY, 2015, 54 : 94 - 94
  • [40] Microreinduction of injectable anti-TNF therapy in Patients with Inflammatory Bowel Disease
    Ligler, Robin
    Horst, Sara
    Duley, Caroline
    Wagnon, Julianne
    Beaulieu, Dawn
    Schwartz, David
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S41 - S42